Board of Scientific Counselors, Coordinating Center for Infectious Diseases (CCID), 66900 [E8-26795]
Download as PDF
<![CDATA[
66900
Federal Register / Vol. 73, No. 219 / Wednesday, November 12, 2008 / Notices
Federal Deposit Insurance Corporation.
Robert E. Feldman,
Executive Secretary.
[FR Doc. E8–26830 Filed 11–10–08; 8:45 am]
percent of the voting shares of Citizens
Bank, N.A., Abilene, Texas.
BILLING CODE 6714–01–P
Board of Governors of the Federal Reserve
System, November 6, 2008.
Jennifer J. Johnson,
Secretary of the Board.
[FR Doc. E8–26808 Filed 11–10–08; 8:45 am]
FEDERAL RESERVE SYSTEM
BILLING CODE 6210–01–S
mstockstill on PROD1PC66 with NOTICES
Formations of, Acquisitions by, and
Mergers of Bank Holding Companies
The companies listed in this notice
have applied to the Board for approval,
pursuant to the Bank Holding Company
Act of 1956 (12 U.S.C. 1841 et seq.)
(BHC Act), Regulation Y (12 CFR Part
225), and all other applicable statutes
and regulations to become a bank
holding company and/or to acquire the
assets or the ownership of, control of, or
the power to vote shares of a bank or
bank holding company and all of the
banks and nonbanking companies
owned by the bank holding company,
including the companies listed below.
The applications listed below, as well
as other related filings required by the
Board, are available for immediate
inspection at the Federal Reserve Bank
indicated. The applications also will be
available for inspection at the offices of
the Board of Governors. Interested
persons may express their views in
writing on the standards enumerated in
the BHC Act (12 U.S.C. 1842(c)). If the
proposal also involves the acquisition of
a nonbanking company, the review also
includes whether the acquisition of the
nonbanking company complies with the
standards in section 4 of the BHC Act
(12 U.S.C. 1843). Unless otherwise
noted, nonbanking activities will be
conducted throughout the United States.
Additional information on all bank
holding companies may be obtained
from the National Information Center
website at www.ffiec.gov/nic/.
Unless otherwise noted, comments
regarding each of these applications
must be received at the Reserve Bank
indicated or the offices of the Board of
Governors not later than December 5,
2008.
A. Federal Reserve Bank of St. Louis
(Glenda Wilson, Community Affairs
Officer) P.O. Box 442, St. Louis,
Missouri 63166–2034:
1. Mt. Sterling Bancorp, Inc., Mt.
Sterling, Illinois, to acquire 100 percent
of the voting shares of Timewell State
Bank, Timewell, Illinois.
B. Federal Reserve Bank of Dallas (E.
Ann Worthy, Vice President) 2200
North Pearl Street, Dallas, Texas 75201–
2272:
1. Big Country Bancshares, Inc.,
Abilene, Texas, to become a bank
holding company by acquiring 100
VerDate Aug<31>2005
20:12 Nov 10, 2008
Jkt 217001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors,
Coordinating Center for Infectious
Diseases (CCID)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
Times and Dates:
9 a.m.–5 p.m., December 4, 2008.
8:30 a.m.–3:30 p.m., December 5, 2008.
Place: CDC, Global Conference Center,
Building 19, 1600 Clifton Road, NE., Atlanta,
Georgia 30333.
December 4, 2008—Building 19 (Work
Groups meet).
December 5, 2008—Auditorium B3 (Full
Board meets).
Status: Open to the public, limited only by
the space available.
Purpose: The Board of Scientific
Counselors, CCID, provides advice and
guidance to the Director, CDC, and Director,
CCID, in the following areas: program goals
and objectives; strategies; program
organization and resources for infectious
disease prevention and control; and program
priorities.
Matters to be Discussed: Agenda items will
include:
1. Breakout Group Discussions: Vaccine
Trust and Vaccine in Healthcare Workers
(National Center for Preparedness, Detection,
and Control of Infectious Diseases and
National Center for Immunization and
Respiratory Diseases). Discussion will be
how reports, statements and
recommendations of our established advisory
committees (Advisory Council for the
Elimination of Tuberculosis, CDC/HRSA
Advisory Committee) can be presented to the
Work Group and full committee most
efficiently and effectively (National Center
for HIV/AIDS, Viral Hepatitis, STD, and TB
Prevention, (NCHHSTP)). Program
Collaboration and Service Integration
(NCHHSTP) International Activities
(National Center for Zoonotic, Vector-Borne,
and Enteric Diseases, (NCZVED)). Peer
Reviews and Planning and New Technology
(NCZVED).
2. Antimicrobial Resistance (Full Board).
3. Budget and CCID/Office of the Director
Updates (Full Board).
Other agenda items include
announcements, introductions, and follow-
PO 00000
Frm 00066
Fmt 4703
Sfmt 4703
up on actions recommended by the board,
directions, goals, and recommendations.
Agenda items are subject to change as
priorities dictate.
Written comments are welcome and should
be received by the contact person listed
below prior to the opening of the meeting.
Contact Person for More Information:
Harriette Lynch, Office of the Director, CCID,
CDC, Mailstop E–77, 1600 Clifton Road, NE.,
Atlanta, Georgia 30333, Telephone:
(404)498–2726, e-mail: hlynch@cdc.gov.
The Director, Management Analysis and
Services office has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: November 4, 2008.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E8–26795 Filed 11–10–08; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors,
National Center for Health Marketing
(BSC, NCHM)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), CDC announces the
following meeting of the
aforementioned committee:
Times and Dates: 9 a.m.–4:30 p.m.,
December 8, 2008. 9 a.m.–3 p.m., December
9, 2008.
Place: CDC, Tom Harkin Global
Communications Center, 1600 Clifton Road,
NE., Building 21, Auditorium A (Room
1204A), Atlanta, Georgia 30333.
Status: Open to the public, limited only by
the space available. The meeting room
accommodates approximately 60 people.
Purpose: The Secretary, Department of
Health and Human Services (HHS), and, by
delegation, the Director, Centers for Disease
Control and Prevention (CDC), are authorized
under Section 301 (42 U.S.C. 241) and
Section 311 (42 U.S.C. 243) of the Public
Health Service Act (PHSA), as amended to:
develop and implement disease prevention
and control, environmental health, and
health promotion and health education
activities designed to improve the health of
the people of the United States. Under these
and additional PHSA and other authorities,
CDC acts by identifying and defining
preventable health problems; maintaining
active surveillance of diseases through
epidemiologic and laboratory investigations
and data collection, analysis, and
distribution; conducting operational research
aimed at developing and testing effective
disease prevention, control, and health
E:\FR\FM\12NON1.SGM
12NON1
]]>Agencies
[Federal Register Volume 73, Number 219 (Wednesday, November 12, 2008)]
[Notices]
[Page 66900]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-26795]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Board of Scientific Counselors, Coordinating Center for
Infectious Diseases (CCID)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC), announces the following meeting of the aforementioned
committee:
Times and Dates:
9 a.m.-5 p.m., December 4, 2008.
8:30 a.m.-3:30 p.m., December 5, 2008.
Place: CDC, Global Conference Center, Building 19, 1600 Clifton
Road, NE., Atlanta, Georgia 30333.
December 4, 2008--Building 19 (Work Groups meet).
December 5, 2008--Auditorium B3 (Full Board meets).
Status: Open to the public, limited only by the space available.
Purpose: The Board of Scientific Counselors, CCID, provides
advice and guidance to the Director, CDC, and Director, CCID, in the
following areas: program goals and objectives; strategies; program
organization and resources for infectious disease prevention and
control; and program priorities.
Matters to be Discussed: Agenda items will include:
1. Breakout Group Discussions: Vaccine Trust and Vaccine in
Healthcare Workers (National Center for Preparedness, Detection, and
Control of Infectious Diseases and National Center for Immunization
and Respiratory Diseases). Discussion will be how reports,
statements and recommendations of our established advisory
committees (Advisory Council for the Elimination of Tuberculosis,
CDC/HRSA Advisory Committee) can be presented to the Work Group and
full committee most efficiently and effectively (National Center for
HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, (NCHHSTP)).
Program Collaboration and Service Integration (NCHHSTP)
International Activities (National Center for Zoonotic, Vector-
Borne, and Enteric Diseases, (NCZVED)). Peer Reviews and Planning
and New Technology (NCZVED).
2. Antimicrobial Resistance (Full Board).
3. Budget and CCID/Office of the Director Updates (Full Board).
Other agenda items include announcements, introductions, and
follow-up on actions recommended by the board, directions, goals,
and recommendations.
Agenda items are subject to change as priorities dictate.
Written comments are welcome and should be received by the
contact person listed below prior to the opening of the meeting.
Contact Person for More Information: Harriette Lynch, Office of
the Director, CCID, CDC, Mailstop E-77, 1600 Clifton Road, NE.,
Atlanta, Georgia 30333, Telephone: (404)498-2726, e-mail:
hlynch@cdc.gov.
The Director, Management Analysis and Services office has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both the CDC and the Agency for Toxic Substances and
Disease Registry.
Dated: November 4, 2008.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. E8-26795 Filed 11-10-08; 8:45 am]
BILLING CODE 4163-18-P
